Skip to main content
TipRanks
Go Ultimate75% OFF

Tate & Lyle (TATYY) AI Stock Analysis

19 Followers
TATYY

Tate & Lyle

(Other OTC:TATYY)

Select Model
Rating:64Neutral
Price Target:$32.00▲(7.86% Upside)
Action:reiterated
Date:11/09/26

The score is supported most by positive earnings-call execution and moderately favorable technical positioning. These strengths are tempered by declining profitability and returns, increased leverage, volatile cash conversion, and a relatively full P/E valuation.

Positive Factors
Specialty ingredient solutionsTate & Lyle operates in specialty ingredients rather than relying solely on commodity products. Its formulation expertise and application support address customer needs such as sugar reduction, clean labels, texture and nutrition, which can deepen relationships and support more resilient margins.
Negative Factors
Higher leverageThe substantial increase in debt has reduced balance-sheet flexibility and makes the company more sensitive to weaker profits or cash generation. Higher leverage can constrain investment and capital allocation choices while increasing the importance of sustained operating performance.

Tate & Lyle (TATYY) vs. SPDR S&P 500 ETF (SPY)

-20%-10%0%10%20%30%40%50%60%TATYY+52.92%SPY+15.52%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$6.99B
Dividend Yield
3.50%
Average Volume (3M)
268
Price to Earnings (P/E)
25.3
Beta (1Y)
0.50
Revenue Growth
21.44%
EPS Growth
48.65%
Country
US
Employees
4,840
Sector
Consumer Defensive
Sector Strength
62
Industry
Packaged Foods

Tate & Lyle Business Overview & Revenue Model

Company Description

Tate & Lyle PLC, along with its subsidiaries, offers a diverse portfolio of ingredients and specialized solutions catering to the food, beverage, and other industrial sectors. Its global footprint spans the United States, the United Kingdom, continen...

How the Company Makes Money

Tate & Lyle makes money primarily by manufacturing and selling specialty food and beverage ingredients to business customers (B2B), especially large and mid-sized packaged food, beverage, and consumer health/nutrition product manufacturers. Revenue i...

Tate & Lyle Earnings Call Summary

Earnings Call Date:Nov 05, 2026(Q2-2027)|% Change Since:-2.56%|Next Earnings Date:May 27, 2027
Earnings Call SentimentPositive

The call was predominantly positive. Tate & Lyle reported a return to volume-led growth, strong cash generation, continued pipeline and fiber momentum, an on-track bio-gums project, progress on the Ingredion transaction, and maintained full-year guidance. These positives were tempered by a challenging European consumer environment, muted North American consumer demand, prolonged Middle East-related pressures, and a tougher and volatile cost and contracting environment.

Positive Updates

Return to Volume-Led Revenue Growth
The group performed well in the first half, with revenue up 1% and volume mix up 3%. Excluding bulk sweeteners and co-products in Europe and U.S. tariff reimbursements, revenue was up 2% and volume mix was up 4%.

Negative Updates

More Pronounced Middle East and Inflationary Pressures
The Middle East conflict has lasted longer than anticipated, and its impact has become more pronounced, particularly in Europe. The company is facing an inflationary environment and plans to pass inflation through as it renews customer framework agreements for calendar year 2027.

Company Guidance

Tate & Lyle is maintaining its outlook for the full year ending 31st of March 2027; H2 versus H1 is not expected to involve “a significant step-up,” with the full-year outcome dependent on developments in calendar year ’27, while the company intends to pass through cost inflation through 2027 calendar year framework agreements and seek to offset it through procurement activities and operational discipline. The bio-gum consolidation project is “proceeding as we anticipated and is on track,” fiber is expected to accelerate and continue growing through the next 12 to 18 months, and completion of the Ingredion transaction is still expected in the second half of calendar year 2027.

Tate & Lyle Financial Statement Overview

Summary

Revenue growth, solid gross profitability, positive cash flow, and improved 2026 free cash flow are offset by declining operating and net margins, higher leverage, lower returns on equity, and volatile cash generation.

Income Statement

63Positive

Balance Sheet

57Neutral

Cash Flow

61Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue2.00B2.01B1.74B1.65B1.75B1.38B
Gross Profit-105.00M919.00M706.00M851.00M733.00M514.00M
EBITDA412.22M413.00M254.00M345.00M279.00M168.00M
Net Income97.00M97.00M143.00M188.00M190.00M236.00M
Balance Sheet
Total Assets3.67B3.67B3.73B2.28B2.51B3.25B
Cash, Cash Equivalents and Short-Term Investments344.02M344.02M334.00M437.00M475.00M112.00M
Total Debt1.29B1.29B1.31B590.00M713.00M679.00M
Total Liabilities2.07B2.07B2.14B1.04B1.32B1.63B
Stockholders Equity1.60B1.60B1.59B1.24B1.19B1.62B
Cash Flow
Free Cash Flow122.44M123.98M43.00M98.00M-12.00M-45.00M
Operating Cash Flow239.20M241.87M164.00M208.00M66.00M103.00M
Investing Cash Flow-121.89M-122.97M-630.00M-20.00M835.00M-113.00M
Financing Cash Flow-106.39M-107.72M367.00M-215.00M-598.00M-247.00M

Tate & Lyle Technical Analysis

Technical Analysis SentimentNegative
Last Price29.67

Price Trends

50DMA29.93Negative
100DMA29.90Negative
200DMA25.78Positive

Market Momentum

MACD-0.03Positive
RSI40.53Neutral
STOCH-0.06Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TATYY, the sentiment is Negative. The current price of 29.67 is below the 20-day moving average (MA) of 30.09, below the 50-day MA of 29.93, and above the 200-day MA of 25.78, indicating a neutral trend. The MACD of -0.03 indicates Positive momentum. The RSI at 40.53 is Neutral, neither overbought nor oversold. The STOCH value of -0.06 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TATYY.

Tate & Lyle Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

TATYY against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
DARDAR76Outperform$8.67B10.4616.72%―15.79%687.52%
MZTIMZTI74Outperform$3.02B17.4816.83%3.60%-0.94%2.86%
SENEASENEA74Outperform$1.18B10.1115.60%―12.06%100.55%
TATYYTATYY64Neutral$3.28B25.276.12%3.50%21.44%48.65%
INGRINGR63Neutral$5.86B10.5912.58%3.49%-0.98%-12.90%
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
WESTWEST54Neutral$834.62M-14.89-21.74%―16.29%42.55%

* Consumer Defensive Sector Average

Performance Comparison

0%50%100%TATYYDARMZTISENEAINGRWESTDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TATYY and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TATYYTate & Lyle Plc Sponsored Adr29.6710.5555.15%
DARDarling Ingredients55.9920.9459.74%
MZTIMarzetti Company110.97-54.02-32.74%
SENEASeneca Foods176.4750.6940.30%
INGRIngredion94.14-9.86-9.48%
WESTWestrock Coffee Company8.344.0895.77%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 09, 2026